Respeecher company
They leverage recent breakthroughs in the field of machine learning called deep learning which allow artificial neural networks to produce high quality synthetic speech. Up until now, these techniques have mainly been used for text-to-speech conversion. Because text contains very little prosodic information, this results in a rather monotone output. By doing speech-to-speech, we circumvent this problem, copying the intonation of the input speech to the output.
Investors
Investors Number:
4
Technology:
P4 Medicine
Headquarters:
Kyiv, Kyyiv, Ukraine
Founded Date:
2018-02-01
Industry:
Artificial Intelligence, Data and Analytics, Hardware, Information Technology, Science and Engineering, Software
Employee Number:
11-50
Last Funding Type:
Angel
Funding Status:
Seed
Investor Type:
For Profit
Total Funding:
$675.5K
Estimated Revenue:
Less than $1M

%20.jpg)

%20.jpg)



.png)







